Showing 2061-2070 of 8732 results for "".
DermWireTV: Ped Derm Salaries; Skin Cancer Symposium Kicks Off; Pandemic Self Care Stats
https://practicaldermatology.com/topics/practice-management/dermwiretv-ped-derm-salaries-skin-cancer-symposium-kicks-off-pandemic-self-care-stats/19910/According to the Society for Pediatric Dermatology’s 2020 Pediatric Dermatology Physician Compensation Report, salaries have increased 37% since 2014. Pediatric dermatologist Mercedes Gonzalez, MD comments. The inaugural Skin Cancer Symposium is underway and the Symposium for Inflammatory Disease kiAsk Me Anything: Mona Sadeghpour, MD
https://practicaldermatology.com/youngmd-connect/wrap-ups/ask-me-anything-mona-sadeghpour-md/24215/An intimate YoungMD Connect virtual mentorship event encourages exchange of ideas, advice, and feedback.Cultural and Aesthetic Considerations in Patients with Skin of Color
https://practicaldermatology.com/programs/practical-dermatology/cultural-and-aesthetic-considerations-in-patients-with-skin-of-color/24211/Culture is influenced by the prevalent art, customs, religions, and social institutions of one’s environment. As the human population continues to evolve, the world population is becoming more multicultural and multiethnic. By the year 2050, approximately 50% of the US population will include peopleClose Up With Gil Yosipovitch, MD
https://practicaldermatology.com/columns/physician-spotlight/close-up-with-gil-yosipovitch-md/24002/JAK Inhibitors Make the Cut for Alopecia Areata
https://practicaldermatology.com/topics/hair-nails/jak-inhibitors-make-the-cut-for-alopecia-areata/23935/JAK inhibitor approvals increase the opportunity for patients with alopecia areata to experience “life-changing” results.Can You Afford to Opt Out of Medicare?
https://practicaldermatology.com/topics/practice-management/can-you-afford-to-opt-out-of-medicare/23884/What to consider when making the the decision and the steps to take.10 Steps to Building Content That Gets Results For Your Practice in 2023
https://practicaldermatology.com/topics/practice-management/10-steps-to-building-content-that-gets-results-for-your-practice-in-2023/23846/Editorial calendars can help organize your marketing content for the year ahead.Assessing the Pediatric Dermatology Workforce
https://practicaldermatology.com/topics/pediatric/assessing-the-pediatric-dermatology-workforce/23834/Physician Spotlight: Steven R. Feldman, MD, PhD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-4/23801/DermWireTV: Sotyktu Approval, Cetaphil at 75, Psoriasis/Depression Link
https://practicaldermatology.com/topics/psoriasis/dermwiretv-sotyktu-approval-cetaphil-at-75-psoriasisdepression-link/20138/FDA has approved Bristol Myers Squibb’s Sotyktu (deucravacitinib) for the oral treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. April Armstrong, MD discusses the first TYK-2 inhibitor approved for psoriasis. As Cetaphil (Galderma)